The window of opportunity for treating vulvovaginal atrophy in menopause: Insights from oestrogen receptor distribution and age-related changes | Synapse
March 3, 2026
The window of opportunity for treating vulvovaginal atrophy in menopause: Insights from oestrogen receptor distribution and age-related changes
Puntos clave
Vulvovaginal atrophy treatment appears effective, especially when targeting oestrogen receptor activity.
Key metric highlights that hormonal therapy can significantly improve symptoms in middle-aged women.
Observational analysis reveals insights from oestrogen receptor distribution and age-related changes.
This may enable timely interventions in menopause, suggesting that early treatment is crucial.